Yokogawa K - Search Results

1

Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice.

Yokogawa K, Yonekawa M, Tamai I, Ohashi R, Tatsumi Y, Higashi Y, Nomura M, Hashimoto N, Nikaido H, Hayakawa J, Nezu J, Oku A, Shimane M, Miyamoto K, Tsuji A. Yokogawa K, et al. Hepatology. 1999 Oct;30(4):997-1001. doi: 10.1002/hep.510300423. Hepatology. 1999. PMID: 10498652

2

Characteristics of L-carnitine transport in cultured human hepatoma HLF cells.

Yokogawa K, Miya K, Tamai I, Higashi Y, Nomura M, Miyamoto K, Tsuji A. Yokogawa K, et al. J Pharm Pharmacol. 1999 Aug;51(8):935-40. doi: 10.1211/0022357991773195. J Pharm Pharmacol. 1999. PMID: 10504033

3

Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.

Higashi Y, Yokogawa K, Takeuchi N, Tamai I, Nomura M, Hashimoto N, Hayakawa JI, Miyamoto KI, Tsuji A. Higashi Y, et al. Among authors: yokogawa k. J Pharm Pharmacol. 2001 Apr;53(4):527-33. doi: 10.1211/0022357011775631. J Pharm Pharmacol. 2001. PMID: 11341370

4

Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.

Yokogawa K, Higashi Y, Tamai I, Nomura M, Hashimoto N, Nikaido H, Hayakawa J, Miyamoto K, Tsuji A. Yokogawa K, et al. J Pharmacol Exp Ther. 1999 Apr;289(1):224-30. J Pharmacol Exp Ther. 1999. PMID: 10087008

5

P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice.

Yokogawa K, Takahashi M, Tamai I, Konishi H, Nomura M, Moritani S, Miyamoto K, Tsuji A. Yokogawa K, et al. Pharm Res. 1999 Aug;16(8):1213-8. doi: 10.1023/a:1018993312773. Pharm Res. 1999. PMID: 10468022

6

In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).

Minamino T, Tamai M, Itoh Y, Tatsumi Y, Nomura M, Yokogawa K, Suzuki H, Sugiyama Y, Ohshima T, Miyamoto K. Minamino T, et al. Among authors: yokogawa k. Jpn J Cancer Res. 1999 Oct;90(10):1171-8. doi: 10.1111/j.1349-7006.1999.tb00692.x. Jpn J Cancer Res. 1999. PMID: 10595747 Free PMC article.

7

Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.

Jin M, Shimada T, Yokogawa K, Nomura M, Kato Y, Tsuji A, Miyamoto K. Jin M, et al. Among authors: yokogawa k. Int J Pharm. 2006 Feb 17;309(1-2):81-6. doi: 10.1016/j.ijpharm.2005.11.015. Epub 2005 Dec 27. Int J Pharm. 2006. PMID: 16384676

8

Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice.

Yokogawa K, Miya K, Sekido T, Higashi Y, Nomura M, Fujisawa R, Morito K, Masamune Y, Waki Y, Kasugai S, Miyamoto K. Yokogawa K, et al. Endocrinology. 2001 Mar;142(3):1228-33. doi: 10.1210/endo.142.3.8024. Endocrinology. 2001. PMID: 11181539

9

Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.

Itoh Y, Tamai M, Yokogawa K, Nomura M, Moritani S, Suzuki H, Sugiyama Y, Miyamoto K. Itoh Y, et al. Among authors: yokogawa k. Anticancer Res. 2002 May-Jun;22(3):1649-53. Anticancer Res. 2002. PMID: 12168849

10

Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.

Shimada T, Nomura M, Yokogawa K, Endo Y, Sasaki T, Miyamoto K, Yonemura Y. Shimada T, et al. Among authors: yokogawa k. J Pharm Pharmacol. 2005 Feb;57(2):177-81. doi: 10.1211/0022357055380. J Pharm Pharmacol. 2005. PMID: 15720780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters